Brevan Howard Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$32.2M |
| 2 |
Global X Uranium ETF
URA
|
+$16.9M |
| 3 |
CND.WS
Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CND.WS
|
+$4.73M |
| 4 |
EXE
Expand Energy Corp
EXE
|
+$3.78M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$2.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$15.5M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$13.8M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$9.4M |
| 4 |
iShares MSCI South Korea ETF
EWY
|
+$5.34M |
| 5 |
CND
Concord Acquisition Corp.
CND
|
+$4.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 96.2% |
| 2 | Healthcare | 1.77% |
| 3 | Financials | 0.86% |
| 4 | Technology | 0.35% |
| 5 | Real Estate | 0.26% |
Similar funds
Brevan Howard Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Brevan Howard Capital Management held 63 positions worth $2.43B, up 30% from $1.87B the previous quarter. Its ten largest holdings account for 91% of the portfolio.
Brevan Howard Capital Management's Q2 2022 filing shows 29 new, 10 increased, 3 reduced and 15 closed positions. Its largest new stake was Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50: 3,580,674 shares worth $3.83M. The largest sale was Baidu, an estimated $15.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, down from 97% a quarter earlier, followed by Healthcare and Financials.
- Brevan Howard Capital Management's largest Q2 2022 buy was Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50: 3,580,674 shares worth $3.83M.
- Brevan Howard Capital Management added most to Moderna in Q2 2022, an estimated $32.2M increase.
- Brevan Howard Capital Management's biggest Q2 2022 reduction was Atomera, cutting an estimated $349K.
- Brevan Howard Capital Management fully exited Baidu in Q2 2022, selling an estimated $15.5M.
- Brevan Howard Capital Management's ten largest holdings make up 91% of its $2.43B portfolio in Q2 2022.
- Brevan Howard Capital Management opened 29 new positions and closed 15 in Q2 2022.
- Brevan Howard Capital Management's portfolio value rose 30% quarter-over-quarter to $2.43B.
Based on Brevan Howard Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.